EUR 12.25
(0.82%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 235.64 Million EUR | -98.0% |
2022 | 504.89 Million EUR | 9.57% |
2021 | 460.77 Million EUR | 7.01% |
2020 | 430.57 Million EUR | -2.1% |
2019 | 439.8 Million EUR | 7.94% |
2018 | 407.44 Million EUR | 4.87% |
2017 | 388.52 Million EUR | 2.3% |
2016 | 379.8 Million EUR | 12.27% |
2015 | 338.29 Million EUR | -4.04% |
2014 | 352.53 Million EUR | -52.92% |
2013 | 748.72 Million EUR | -2.56% |
2012 | 768.43 Million EUR | 45.27% |
2011 | 528.96 Million EUR | -0.96% |
2010 | 534.06 Million EUR | -23.7% |
2009 | 699.99 Million EUR | -0.76% |
2008 | 705.38 Million EUR | 12.8% |
2007 | 625.31 Million EUR | 39.83% |
2006 | 447.2 Million EUR | 496.77% |
2005 | 74.93 Million EUR | -75.73% |
2004 | 308.78 Million EUR | -9.2% |
2003 | 340.08 Million EUR | 13.3% |
2002 | 300.15 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 61.86 Million EUR | 1.21% |
2024 Q2 | 61.86 Million EUR | 0.0% |
2023 FY | 10.07 Million EUR | -98.0% |
2023 Q4 | 61.12 Million EUR | -1.26% |
2023 Q2 | 57.18 Million EUR | 0.0% |
2023 Q1 | 57.18 Million EUR | 18.29% |
2023 Q3 | 61.9 Million EUR | 8.26% |
2022 Q3 | 48.34 Million EUR | 658.79% |
2022 Q1 | 51.64 Million EUR | 1059.44% |
2022 Q4 | 48.34 Million EUR | 0.0% |
2022 Q2 | 6.37 Million EUR | -87.66% |
2022 FY | 504.89 Million EUR | 9.57% |
2021 FY | 460.77 Million EUR | 7.01% |
2021 Q1 | 42.67 Million EUR | 665.64% |
2021 Q2 | 6.58 Million EUR | -84.56% |
2021 Q4 | 4.45 Million EUR | -90.48% |
2021 Q3 | 46.78 Million EUR | 610.16% |
2020 Q3 | 48.68 Million EUR | 515.87% |
2020 Q2 | 7.9 Million EUR | -83.65% |
2020 FY | 430.57 Million EUR | -2.1% |
2020 Q1 | 48.34 Million EUR | 839.6% |
2020 Q4 | 5.57 Million EUR | -88.55% |
2019 Q4 | 5.14 Million EUR | -89.71% |
2019 Q2 | 54.89 Million EUR | 0.0% |
2019 Q1 | 54.89 Million EUR | 10.01% |
2019 FY | 439.8 Million EUR | 7.94% |
2019 Q3 | 49.97 Million EUR | -8.96% |
2018 FY | 407.44 Million EUR | 4.87% |
2018 Q1 | 48.04 Million EUR | 9.24% |
2018 Q2 | 48.04 Million EUR | 0.0% |
2018 Q3 | 49.9 Million EUR | 3.87% |
2018 Q4 | 49.9 Million EUR | 0.0% |
2017 Q1 | 50.09 Million EUR | -50.61% |
2017 Q4 | 43.97 Million EUR | 0.0% |
2017 Q3 | 43.97 Million EUR | -12.21% |
2017 FY | 388.52 Million EUR | 2.3% |
2017 Q2 | 50.09 Million EUR | 0.0% |
2016 Q2 | 95.29 Million EUR | 1.36% |
2016 Q1 | 94 Million EUR | 44.93% |
2016 Q3 | 89.07 Million EUR | -6.53% |
2016 Q4 | 101.43 Million EUR | 13.87% |
2016 FY | 379.8 Million EUR | 12.27% |
2015 Q2 | 91.05 Million EUR | 0.48% |
2015 FY | 338.29 Million EUR | -4.04% |
2015 Q4 | 64.86 Million EUR | -29.3% |
2015 Q3 | 91.75 Million EUR | 0.76% |
2015 Q1 | 90.62 Million EUR | 143.92% |
2014 FY | 352.53 Million EUR | -52.92% |
2014 Q4 | -206.34 Million EUR | -214.63% |
2014 Q3 | 180 Million EUR | -3.93% |
2014 Q2 | 187.36 Million EUR | -2.16% |
2014 Q1 | 191.5 Million EUR | -0.83% |
2013 Q2 | 183.84 Million EUR | -4.67% |
2013 Q3 | 178.91 Million EUR | -2.68% |
2013 Q4 | 193.1 Million EUR | 7.93% |
2013 FY | 748.72 Million EUR | -2.56% |
2013 Q1 | 192.85 Million EUR | -1.54% |
2012 Q4 | 195.87 Million EUR | -35.36% |
2012 Q1 | 196.99 Million EUR | 0.0% |
2012 Q2 | 72.53 Million EUR | -63.18% |
2012 Q3 | 303.02 Million EUR | 317.75% |
2012 FY | 768.43 Million EUR | 45.27% |
2011 FY | 528.96 Million EUR | -0.96% |
2010 FY | 534.06 Million EUR | -23.7% |
2009 FY | 699.99 Million EUR | -0.76% |
2008 FY | 705.38 Million EUR | 12.8% |
2007 FY | 625.31 Million EUR | 39.83% |
2006 FY | 447.2 Million EUR | 496.77% |
2005 FY | 74.93 Million EUR | -75.73% |
2004 FY | 308.78 Million EUR | -9.2% |
2003 FY | 340.08 Million EUR | 13.3% |
2002 FY | 300.15 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Guerbet SA | 550.79 Million EUR | 57.217% |
Nexus AG | 44.98 Million EUR | -423.839% |
Bastide Le Confort Médical SA | 1.91 Million EUR | -12211.86% |
Revenio Group Oyj | 18.8 Million EUR | -1153.452% |
Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 81.712% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 76.954% |
LNA Santé SA | 178.1 Million EUR | -32.307% |
Siemens Healthineers AG | 5.59 Billion EUR | 95.791% |
Medios AG | 23.03 Million EUR | -923.004% |
Equasens Société anonyme | 14.67 Million EUR | -1506.333% |
Stratec SE | 41.95 Million EUR | -461.644% |